 
                            
                                    Cancer                                
                                                            ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
                                    Cardiovascular                                
                                                            February 4, 2014
                                
                                    Cardiovascular                                
                                                            January 17, 2014
                                
                                    Research                                
                                                            November 25, 2013
                                
                                    Cardiovascular                                
                                                            November 18, 2013
                                Sign up to receive email notifications
Explore more topics
 Sign up
 Sign up
               
                              Mayo Clinic Connect
An online patient support community
